Eva Schlede

757 total citations
33 papers, 554 citations indexed

About

Eva Schlede is a scholar working on Small Animals, Dermatology and Pharmacology. According to data from OpenAlex, Eva Schlede has authored 33 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Small Animals, 8 papers in Dermatology and 8 papers in Pharmacology. Recurrent topics in Eva Schlede's work include Animal testing and alternatives (12 papers), Contact Dermatitis and Allergies (8 papers) and Pesticide Exposure and Toxicity (7 papers). Eva Schlede is often cited by papers focused on Animal testing and alternatives (12 papers), Contact Dermatitis and Allergies (8 papers) and Pesticide Exposure and Toxicity (7 papers). Eva Schlede collaborates with scholars based in Germany, United States and France. Eva Schlede's co-authors include Ingrid Gerner, Allan H. Conney, R. Kuntzman, H. J. Merker, G. Stropp, R. Roll, Elke Genschow, Horst Spielmann, Holger Lessmann and Werner Aberer and has published in prestigious journals such as Life Sciences, Food and Chemical Toxicology and Toxicology.

In The Last Decade

Eva Schlede

33 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Schlede Germany 15 137 117 116 94 85 33 554
Jeffrey D. Vassallo United States 11 138 1.0× 112 1.0× 84 0.7× 368 3.9× 79 0.9× 16 818
Corie A. Ellison United States 18 119 0.9× 261 2.2× 81 0.7× 169 1.8× 274 3.2× 34 749
Ruth Pendlington United Kingdom 16 116 0.8× 43 0.4× 32 0.3× 153 1.6× 107 1.3× 25 473
Wera Teubner Germany 14 220 1.6× 105 0.9× 205 1.8× 370 3.9× 116 1.4× 23 999
Kirk Arvidson United States 11 81 0.6× 40 0.3× 65 0.6× 24 0.3× 132 1.6× 13 444
Eva Bay Wedebye Denmark 15 104 0.8× 71 0.6× 57 0.5× 91 1.0× 570 6.7× 37 946
Orest T. Macina United States 14 53 0.4× 57 0.5× 17 0.1× 58 0.6× 121 1.4× 27 528
Albert R. Cunningham United States 15 34 0.2× 40 0.3× 27 0.2× 45 0.5× 158 1.9× 42 601
Jacky Van Gompel Belgium 12 77 0.6× 100 0.9× 71 0.6× 7 0.1× 142 1.7× 18 668
Emile A. Hermann United States 8 27 0.2× 122 1.0× 36 0.3× 11 0.1× 113 1.3× 12 471

Countries citing papers authored by Eva Schlede

Since Specialization
Citations

This map shows the geographic impact of Eva Schlede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Schlede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Schlede more than expected).

Fields of papers citing papers by Eva Schlede

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Schlede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Schlede. The network helps show where Eva Schlede may publish in the future.

Co-authorship network of co-authors of Eva Schlede

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Schlede. A scholar is included among the top collaborators of Eva Schlede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Schlede. Eva Schlede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schlede, Eva, et al.. (2005). Oral acute toxic class method: A successful alternative to the oral LD50 test. Regulatory Toxicology and Pharmacology. 42(1). 15–23. 45 indexed citations
3.
Schlede, Eva, Werner Aberer, T. Fuchs, et al.. (2004). Chemical Substances and Contact Allergy‐244 Substances Ranked According to Allergenic Potency. ChemInform. 35(18). 1 indexed citations
4.
Schlede, Eva, Werner Aberer, T. Fuchs, et al.. (2003). Chemical substances and contact allergy—244 substances ranked according to allergenic potency. Toxicology. 193(3). 219–259. 55 indexed citations
5.
Holzhütter, Hermann−Georg, et al.. (2003). Dermal and inhalation acute toxic class methods: test procedures and biometric evaluations for the Globally Harmonized Classification System. Archives of Toxicology. 77(5). 243–254. 8 indexed citations
7.
Gerner, Ingrid & Eva Schlede. (2002). Introduction of in vitro data into local irritation/corrosion testing strategies by means of SAR considerations: assessment of chemicals. Toxicology Letters. 127(1-3). 169–175. 14 indexed citations
8.
Schlede, Eva, et al.. (1998). The dermal acute toxic class method: test procedures and biometric evaluations. Archives of Toxicology. 72(12). 751–762. 6 indexed citations
9.
Silva, O. de, M. Cottin, R. Roguet, et al.. (1997). Evaluation of eye irritation potential: statistical analysis and tier testing strategies. Food and Chemical Toxicology. 35(1). 159–164. 16 indexed citations
10.
Schlede, Eva, et al.. (1997). The inhalation acute toxic class method: test procedures and biometric evaluations. Archives of Toxicology. 71(9). 537–549. 2 indexed citations
11.
Pauluhn, J., et al.. (1996). Acute inhalation toxicity testing: considerations of technical and regulatory aspects. Archives of Toxicology. 71(1-2). 1–10. 10 indexed citations
12.
Schlede, Eva, et al.. (1995). The international validation study of the acute toxic class method (oral). Archives of Toxicology. 69(10). 659–670. 37 indexed citations
13.
Schlede, Eva, et al.. (1995). Testing for skin sensitization according to the notification procedure for new chemicals: the Magnusson and Kligman test. Contact Dermatitis. 32(1). 1–4. 22 indexed citations
14.
Schlede, Eva, et al.. (1992). A national validation study of the acute-toxic-class method—an alternative to the LD50 test. Archives of Toxicology. 66(7). 455–470. 46 indexed citations
15.
Schlede, Eva & Ivar Roots. (1985). Benzo(a)pyrene metabolism in hepatic microsomes from female da rats with a genetic sparteine oxidation deficiency. Toxicology Letters. 29(1). 5–10. 1 indexed citations
16.
Schlede, Eva & Horst Scholz. (1974). No differences in benzo(a)pyrene hydroxylase activity in the human immature placenta and in the human fetal liver from cigarette smoking and nonsmoking women. Journal of Perinatal Medicine. 2(3). 189–195. 3 indexed citations
17.
Schlede, Eva & H. J. Merker. (1974). Benzo(a)pyrene hydroxylase activity in the whole implantation site, decidua, placenta and fetal membranes of the rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 282(1). 59–73. 3 indexed citations
18.
Schlede, Eva, et al.. (1974). Decreased effect of phenobarbital treatment on microsomal drug metabolizing enzyme activity during gestation. Naunyn-Schmiedeberg s Archives of Pharmacology. 281(4). 341–355. 21 indexed citations
19.
Schlede, Eva & H. J. Merker. (1972). Effect of benzo(?)pyrene treatment on the benzo(?)pyrene hydroxylase activity in maternal liver, placenta, and fetus of the rat during day 13 to day 18 of gestation. Naunyn-Schmiedeberg s Archives of Pharmacology. 272(1). 89–100. 26 indexed citations
20.
Kewitz, H. & Eva Schlede. (1968). Ausscheidung und Verteilung von Hexamethylentetramin und Formaldehyd. Naunyn-Schmiedeberg s Archives of Pharmacology. 259(2). 211–212. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026